Profile
Graham Melrose is the founder of Recce Pharmaceuticals Ltd., which was founded in 2007.
He held the title of Executive Director & Chief Research Officer from 2019 to 2020.
Dr. Melrose is also the founder of Chemeq Ltd.
In his former job, he was the Executive Director & Head-Research at Johnson & Johnson (Austrial) Pty Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RECCE PHARMACEUTICALS LTD.
18.16% | 2023-09-17 | 37,028,311 ( 18.16% ) | 16 M $ | 2024-04-29 |
Former positions of Graham Melrose
| Companies | Position | End |
|---|---|---|
| RECCE PHARMACEUTICALS LTD | Founder | 2020-07-02 |
Chemeq Ltd.
 Chemeq Ltd. BiotechnologyHealth Technology Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia. | Founder | - |
| Johnson & Johnson (Austrial) Pty Ltd. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RECCE PHARMACEUTICALS LTD | Health Technology |
| Private companies | 2 |
|---|---|
Chemeq Ltd.
Chemeq Ltd. BiotechnologyHealth Technology Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia. | Health Technology |
| Johnson & Johnson (Austrial) Pty Ltd. |
- Stock Market
- Insiders
- Graham Melrose
